Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) FCF Margin (2017 - 2025)

Historic FCF Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 0.56%.

  • Organogenesis Holdings' FCF Margin fell 47600.0% to 0.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.1%, marking a year-over-year decrease of 119600.0%. This contributed to the annual value of 0.87% for FY2024, which is 6500.0% down from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' FCF Margin is 0.56%, which was down 47600.0% from 36.15% recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' FCF Margin ranged from a high of 10.67% in Q2 2021 and a low of 36.15% during Q2 2025
  • In the last 5 years, Organogenesis Holdings' FCF Margin had a median value of 0.98% in 2023 and averaged 2.03%.
  • Per our database at Business Quant, Organogenesis Holdings' FCF Margin skyrocketed by 287700bps in 2021 and then crashed by -383400bps in 2025.
  • Organogenesis Holdings' FCF Margin (Quarter) stood at 9.95% in 2021, then plummeted by -125bps to 2.47% in 2022, then soared by 396bps to 7.32% in 2023, then decreased by -18bps to 5.98% in 2024, then tumbled by -91bps to 0.56% in 2025.
  • Its FCF Margin stands at 0.56% for Q3 2025, versus 36.15% for Q2 2025 and 27.18% for Q1 2025.